Alcon

• Go to www.alconlabs.com

Alcon is a Platinum level sponsor of the American Optometric Association.

Bringing quality eye care to people around the world

Alcon, Inc. is dedicated to improving vision and eye health by providing the best health care products and solutions for treating diseases and conditions of the eye. Our leadership, expertise and breadth of product offerings have developed over 65 years and we have made it our mission to enhance, preserve and restore vision around the world. At Alcon, we understand that being the world's leading eye care company requires more than just offering high-quality eye care products. Therefore, we are guided by a culture of accountability, steadfast commitment to relationships with eye care professionals and other doctors who prescribe our products. Our commitment spans the globe with more than 15,500 employees in more than 75 countries who work directly with our customers worldwide. It is these dedicated people who make the company's tradition of providing high quality and innovative eye care products to more than 180 markets a reality year after year.

Surgical Product Highlights

Alcon offers the industry's most complete line of ophthalmic surgical products. Alcon's surgical portfolio includes the Infiniti® vision system with OZil® torsional hand piece for cataract procedures, the Allegretto Wave® Eye-Q 400 Hz laser for LASIK vision correction, the Constella® surgical system for vitreoretinal operations, and the AcrySof® family of intraocular lenses (IOLs), including the AcrySof® IQ ReSTOR® and the AcrySof® IQ Toric intraocular lenses that correct cataracts with presbyopia or astigmatism, respectively. Alcon also provides a complete offering of viscoelastics, surgical solutions, surgical packs and other disposable products for eye surgery. In 2010, Alcon's surgical portfolio expanded into the surgical glaucoma market with the Ex-Press^TM glaucoma filtration device. Alcon recently introduced its own femtosecond laser for refractive surgery, the WaveLight® FS200 laser. Our recent acquisition of the LenSx® laser provides Alcon with the leading platform for femtosecond laser technology used for specific steps in cataract surgery.

Pharmaceutical Product Highlights

Since its inception, Alcon has been focused on developing treatments for wide variety of chronic and acute diseases of the eye. The Alcon pharmaceutical portfolio features Travatan Z® ophthalmic solution and Azopt® ophthalmic suspension for IOP lowering, Pataday^TM ophthalmic solution for itching associated with eye allergies, Nevanac® ophthalmic suspension to treat pain and inflammation following cataract surgery, and Vigamox®* ophthalmic solution for treatment of bacterial conjunctivitis. Alcon added Durezol® ophthalmic steroid to its anti-inflammatory product portfolio in 2010. This product is a potent steroid used to treat pain and inflammation associated with ocular surgery. Alcon also launched TobraDex®ST ophthalmic suspension, which is a new combination anti-inflammatory/anti-infective product that targets ocular conditions for which a corticosteroid is indicated and a bacterial infection or risk of bacterial infection exists.

Consumer Product Highlights

Alcon continues to meet the needs of consumers worldwide by providing an innovative line of contact lens care products, artificial tears, over-the-counter allergy eye drops and ocular dietary supplements. Alcon's consumer portfolio boasts the Opti-Free® family of contact lens care products including Opti-Free® RepleniSH® multi-purpose disinfecting solution, Icaps® eye vitamins for healthy eye nutrition and the Systane® family of dry eye products including Systane® Ultra lubricant eyedrops for the temporary relief of burning and irritation due to the dryness of the eye. Alcon's newest formulation in the Systane® family of products is Systane® Balance Lubricant Eye Drops.

*CiproDex® is a registered trademark of Bayer AG. Products licensed to Alcon, Inc. by Bayer Schering Pharma AG.

Alcon U.S. Headquarters,
Alcon Laboratories, Inc., 6201